Chemokine Receptor-5 Δ 32 Mutation is No Risk Factor for Ischemic-Type Biliary Lesion in Liver Transplantation
Journal of Transplantation · 2009
DOI: 10.1155/2009/436515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Transplantation, 2009. Verfasst von Christoph Heidenhain und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral and Transplantation Surgery, Charité-University Medicine of Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, …. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
It has been shown that certain chemokine receptor polymorphisms may correspond to certain complications after organ transplantation. Ischemic-type biliary lesion (ITBL) encounters for major morbidity and mortality in liver transplant recipients. So far, the exact cause for ITBL remains unclear. Certain risk factors for the development of ITBL like donor age and cold ischemic time are well described. In a previous study, a 32-nucleotide deletion of the chemokine receptor-5 Δ 32 (CCR-5 Δ 32) was strongly associated with the incidence of ITBL in adult liver transplantation. This study re-evaluates the association of CCR-5 Δ 32 gene polymorphism and the incidence of ITBL. 169 patients were included into this retrospective analysis. 134 patients were homozygous for wild-type CCR-5, 33 patients heterozygous, and 2 patients were homozygous for CCR-5 Δ 32 mutation. There were no major differences in donor or recipients demographics. No association was found between CCR-5 Δ 32 mutation and the development of ITBL. We conclude that CCR-5 Δ 32 is no risk factor for the development of ITBL in our patient cohort.
Autor:innen und Institutionen
- Department of General, Visceral and Transplantation Surgery, Charité-University Medicine of Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany.
Zitieren
APA
Heidenhain, C., Puhl, G., Moench, C., Lautem, A., & Neuhaus, P. (2009). Chemokine Receptor-5 Δ 32 Mutation is No Risk Factor for Ischemic-Type Biliary Lesion in Liver Transplantation. Journal of Transplantation. https://doi.org/10.1155/2009/436515
Vancouver
Heidenhain C, Puhl G, Moench C, Lautem A, Neuhaus P. Chemokine Receptor-5 Δ 32 Mutation is No Risk Factor for Ischemic-Type Biliary Lesion in Liver Transplantation. Journal of Transplantation. 2009. doi:10.1155/2009/436515
BibTeX
@article{Heidenhain2009,
author = {Heidenhain, Christoph and Puhl, Gero and Moench, Christian and Lautem, Anja and Neuhaus, Peter},
title = {Chemokine Receptor-5 Δ 32 Mutation is No Risk Factor for Ischemic-Type Biliary Lesion in Liver Transplantation},
journal = {Journal of Transplantation},
year = {2009},
doi = {10.1155/2009/436515}
}
EUVIMED